Drug Profile
Etheophazine
Latest Information Update: 01 Jun 2010
Price :
$50
*
At a glance
- Originator Second Military Medical University; Shanghai Wanxing Bio-Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 01 Jun 2010 No development reported - Phase-III for Solid tumours in China (IV)
- 29 Nov 2007 Phase-III clinical trials in Solid tumours in China (IV,Infusion)